AffiliationCRC Department of Medical Oncology, University of Manchester, Christie Hospital NHS Trust, Manchester, UK. firstname.lastname@example.org
MetadataShow full item record
CitationSelective oestrogen receptor downregulator. 2002, 38 Suppl 6:S61-2 Eur. J. Cancer
JournalEuropean Journal of Cancer
- Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
- Authors: Baumann CK, Castiglione-Gertsch M
- Issue date: 2009 Dec
- Faslodex (ICI 182780). an oestrogen receptor downregulator.
- Authors: Howell A
- Issue date: 2000 Sep
- Faslodex (ICI 182, 780), a novel estrogen receptor downregulator--future possibilities in breast cancer.
- Authors: Robertson JF
- Issue date: 2001 Dec
- The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
- Authors: Howell SJ, Johnston SR, Howell A
- Issue date: 2004 Mar
- Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
- Authors: Park WC, Jordan VC
- Issue date: 2002 Feb